Inogen Announces Participation in Upcoming J.P. Morgan Healthcare Conference & Needham Growth Conference
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 36th Annual J.P. Morgan Healthcare Conference in San Francisco and the 20th Annual Needham Growth Conference in New York City.
Inogen’s President and CEO Scott Wilkinson and CFO Alison Bauerlein are scheduled to present on Tuesday, January 9, 2018, at 10:30 a.m. PT at the J.P. Morgan Conference, and on Wednesday, January 17, 2018, at 11:20 a.m. ET at the Needham Growth Conference. Interested parties can access the live audio webcasts of both of these events from the Events section of the Investor Relations page on the Inogen website at www.inogen.com. Webcast replays will be available approximately one hour after the conclusion of each live presentation and will remain available for 90 days.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
Investor Relations Contact:
Matt Bacso, CFA
Source: Inogen, Inc.
Released December 20, 2017